Free Trial

DiaMedica Therapeutics (DMAC) SEC Filings & 10K Form

DiaMedica Therapeutics logo
$5.05 +0.17 (+3.48%)
Closing price 04:00 PM Eastern
Extended Trading
$5.29 +0.24 (+4.75%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent DiaMedica Therapeutics SEC Filings

DateFilerForm TypeView
07/21/2025
7:01 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
7:05 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:41 PM
DiaMedica Therapeutics (Issuer)
Pilnik Richard D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
6:35 AM
DiaMedica Therapeutics (Filer)
Form ARS
03/28/2025
6:14 AM
DiaMedica Therapeutics (Filer)
Form DEF 14A
03/28/2025
6:15 AM
DiaMedica Therapeutics (Filer)
Form DEFA14A
03/17/2025
3:30 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
7:30 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
4:06 PM
DiaMedica Therapeutics (Issuer)
O'Connor Daniel J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:46 PM
DiaMedica Therapeutics (Issuer)
Parsons James T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:31 PM
DiaMedica Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:32 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DMAC) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners